Press release
Global Atherosclerosis Clinical Trials Rise Due to Higher Disease Incidences, H1 Review Till 2017
According to the recently published report Dystrophin (DMD) - Pipeline Review, H1 2017; Dystrophin (DMD) pipeline Target constitutes close to 26 molecules. Out of which approximately 23 molecules are developed by companies and remaining by the universities/institutes.Dystrophin (DMD) - Dystrophin is a cytoplasmic protein. It anchors the extracellular matrix to the cytoskeleton via F-actin. It acts as ligand for dystroglycan. It act as component of the dystrophin-associated glycoprotein complex which accumulates at the neuromuscular junction and at a variety of synapses in the peripheral and central nervous systems and has a structural function in stabilizing the sarcolemma.
Request For Free Sample @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1177495
The report “Dystrophin Pipeline Review H1 2017” outlays comprehensive information on the Dystrophin (DMD) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.
It also reviews key players involved in Dystrophin (DMD) targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 2, 2, 1, 8 and 10 respectively. Similarly, the universities portfolio in Phase I and Preclinical stages comprises 1 and 2 molecules, respectively. Report covers products from therapy areas Genetic Disorders and Musculoskeletal Disorders which include indications Duchenne Muscular Dystrophy and Muscular Dystrophy.
Scope
- The report provides a snapshot of the global therapeutic landscape for Dystrophin (DMD)
- The report reviews Dystrophin (DMD) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Dystrophin (DMD) targeted therapeutics and enlists all their major and minor projects
- The report assesses Dystrophin (DMD) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Dystrophin (DMD) targeted therapeutics
Browse Full Report With TOC @ http://www.marketresearchhub.com/report/dystrophin-dmd-pipeline-review-h1-2017-report.html
Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Dystrophin (DMD)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Dystrophin (DMD) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Dystrophin (DMD) - Overview
Dystrophin (DMD) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Products under Development by Universities/Institutes
Dystrophin (DMD) - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Dystrophin (DMD) - Companies Involved in Therapeutics Development
Asklepios BioPharmaceutical Inc
BioMarin Pharmaceutical Inc
Daiichi Sankyo Company Ltd
Editas Medicine Inc
Genethon SA
Nippon Shinyaku Co Ltd
Pfizer Inc
Sarepta Therapeutics Inc
WAVE Life Sciences Ltd
Dystrophin (DMD) - Drug Profiles
Antisense Oligonucleotide 1 to Activate Dystrophin for Duchenne Muscular Dystrophy - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Antisense Oligonucleotide to Activate Dystrophin for Duchenne Muscular Dystrophy - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Antisense Oligonucleotide to Activate Dystrophin for Duchenne Muscular Dystrophy - Drug Profile
Product Description
Mechanism Of Action
Continue….
Make an Enquiry: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1177495
About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
Contact Details:
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/
Read More Related News: https://www.industrynewsanalysis.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Atherosclerosis Clinical Trials Rise Due to Higher Disease Incidences, H1 Review Till 2017 here
News-ID: 598036 • Views: …
More Releases from Latest Research Reports
Global Siliconized Polyester Coated Steel Market Expected to Grow at a High CAGR …
The global siliconized polyester coated steel market research report offers a detailed analysis of the siliconized polyester coated steel at regional and global level. Which primarily aims important regions such as North America, Europe, China, Japan, Southeast Asia and India. A new market report with a title “Global Siliconized Polyester Coated Steel Market” Research Report 2017 has been recently added to the vast online database of Market Research Hub (MRH).…
Global Two Component Polyurethane Adhesive Market to Surge at a Significant Rate …
The global two component polyurethane adhesive market research report offers a detailed perception of the two component polyurethane adhesive at regional and global level. Which primarily aims important regions such as North America, Europe, China, Japan, Southeast Asia and India. A new market report with a title “Global Two Component Polyurethane Adhesive Market” Research Report 2017 has been recently added to the vast online database of Market Research Hub (MRH).…
Global Smoke Retardant Composite Resin Market to Grow at Notable CAGR during the …
The global smoke retardant composite resin market research report offers a detailed perception of this market at regional and global level. The global smoke retardant composite resin market analysis predicts high growth of the market during the forecast period. In this report, 2017 – 2022 is considered as the forecast years for assessing market size. A new market report with a title “Global Smoke Retardant Composite Resin Market” Research Report…
Global Menthoxypropanediol Market to Rise at a Notable Rate during the Forecast …
This research report is a highly exhaustive analysis of the global Menthoxypropanediol market. It provides an all-inclusive overview of the various applications and end users of the market and how the demand and supply are anticipated to change over the forthcoming years. Market Research Hub (MRH) has recently added a new market report to its vast online database. This research study is titled as “Global Menthoxypropanediol Market” Research Report 2017…
More Releases for Dystrophin
Dystrophin Gene Therapy Market to Hit US $12 billion by 2033, Report by DataM In …
Overview of the Market
The Dystrophin Gene Therapy Market is rapidly evolving as a transformative segment of the broader gene therapy industry. Focused on delivering functional or micro-dystrophin genes to treat Duchenne Muscular Dystrophy (DMD), this market leverages advanced therapeutic approaches such as exon-skipping and adeno-associated virus (AAV)-mediated delivery. With increasing R&D investments, regulatory momentum, and heightened patient demand, the market stands poised for significant growth. Personalized medicine strategies, alongside collaborations…
Dystrophin Gene Therapy Market 2025 | $12B Growth, REGENXBIO & BMS Collaboration …
The Dystrophin Gene Therapy Market reached approximately US$1.91 billion in 2024 and is projected to soar to around US$12 billion by 2033, expanding at a strong compound annual growth rate (CAGR) of 20.6% during the forecast period from 2025 to 2033, according to DataM Intelligence. This rapid growth is fueled by ongoing advancements in gene therapies, a rising prevalence of Duchenne Muscular Dystrophy (DMD), and an increasing patient population with…
Dystrophin Gene Therapy Market - Dystrophin Clinical Trials To Reach US$ 6.98 Bi …
The Dystrophin Gene Therapy Market reached US$ 1.20 billion in 2023 and is expected to reach US$ 6.98 billion by 2031, growing at a CAGR of 22.9% during the forecast period 2024-2031.
The Dystrophin Gene Therapy Market report, released by DataM Intelligence, offers comprehensive insights and thorough analysis of major market trends, growth prospects, and emerging challenges. With a strong focus on actionable intelligence, DataM Intelligence equips businesses with the knowledge…
Dystrophin Market Poised for Significant Growth: A Promise for Muscular Dystroph …
The dystrophin market is experiencing a surge of interest due to its potential to revolutionize the treatment of muscular dystrophy (MD), a debilitating genetic disorder. This press release delves into the current landscape of the dystrophin market, exploring key trends, drivers, and opportunities that will shape its future trajectory.
Get Free Exclusive Sample PDF Copy: @ https://www.reportsanddata.com/download-free-sample/1063
Market Overview and Trends
The global dystrophin market is projected to reach a staggering USD 28.20…
Dystrophin Market to Reach USD 30.22 Billion by 2028 | Vantage Market Research
A New report published by Vantage Market Research titled "Dystrophin Market" report provides an in-depth analysis of global, regional, and country-level market size, market growth by the competitive landscape, segment, share, sales analysis, results of domestic and international market players, value chain. Opportunity analysis, optimization, trade rules, recent developments, strategic market growth analysis, product launches, regional market expansion, and technological innovation during the forecast period 2022-2028. The report also includes…
Global Dystrophin Market to Reach USD 30.22 Billion by 2028 | Vantage Market Res …
The Global Dystrophin Market was valued at USD 1.31 Billion in 2021, and is anticipated to reach USD 30.22 Billion by 2028, exhibiting a CAGR of 45.9% during the forecast period 2022 to 2028.
Market Introduction:
A qualitative report published by Vantage Market Research Dystrophin Market provides in-depth insights of Dystrophin industry. This exclusive report gives a thorough analysis of this dynamic focus of market with a secondary search. The report sheds…
